Spheroids of Bladder Smooth Muscle Cells for Bladder Tissue Engineering

Area of Science:

• Regenerative Medicine
• Tissue Engineering
• Urology

Background:

• Cell-based tissue engineering (TE) aims to improve outcomes for end-stage bladder disease.
• Previous TE approaches using 2D smooth muscle cell (SMC) cultures have faced limitations in efficacy.
• Developing functional bladder substitutes requires robust SMC differentiation and extracellular matrix (ECM) production.

Purpose of the Study:

• To develop and analyze primary bladder-derived 3D SMC spheroids.
• To compare the differentiation, maturation, and ECM production of 3D SMC spheroids against traditional 2D SMC cultures.
• To assess the potential of 3D SMC spheroids for bladder tissue engineering and detrusor regeneration.

Main Methods:

• Primary bladder smooth muscle cells were cultured in 3D spheroid formation.
• Comparative analysis of 3D spheroids and 2D cultures using live-dead staining, qRT-PCR, immunofluorescence, and immunoblotting.
• Evaluation of cell viability, proliferation, differentiation markers (MyH11, α-SMA), and ECM protein expression.

Main Results:

• 3D SMC spheroids demonstrated viability for up to 14 days, with differentiation prioritized over proliferation.
• Spheroids predominantly expressed the late myogenic marker MyH11, indicating advanced differentiation.
• 3D SMC spheroids exhibited significantly higher expression of bladder wall-specific ECM proteins compared to 2D cultures.
• 2D SMC cultures showed higher expression of the general marker α-SMA but less MyH11 compared to spheroids.

Conclusions:

• Primary bladder SMC spheroids represent a superior model for TE compared to 2D cultures.
• The enhanced differentiation and ECM production in spheroids are crucial for developing functional bladder wall substitutes.
• SMC spheroids show significant promise as building blocks for studying detrusor regeneration and advancing bladder TE.